Mountain View, California-based Aerin Medical evaluated its VivAer system in the AERWAY clinical trial.
VivAer, which holds both CE mark and FDA 510(k) approval, uses patented, temperature-controlled radiofrequency energy through a thin, wand-like stylus attached to a console. The stylus is inserted via the nostril to gently remodel the nasal tissue and improve airflow. Aerin Medical featured on Medical Design & Outsourcing’s list of 20 medical device startups you need to know in 2020.
This trial looked at VivAer in the treatment of patients with severe or extreme NAO due to nasal valve collapse (NVC). Results published in Laryngoscope Investigative Otolaryngology demonstrated significant, long-term improvement in NAO symptom burden.
According to a news release, the outcomes showed the …